Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody: EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS*
Background: Receptor activator of nuclear factor-κB ligand is a pivotal osteoclast differentiation factor.
Main Authors: | Furuya, Yuriko, Mori, Kaoru, Ninomiya, Tadashi, Tomimori, Yoshiya, Tanaka, Sakae, Takahashi, Naoyuki, Udagawa, Nobuyuki, Uchida, Kohji, Yasuda, Hisataka |
---|---|
Format: | Online |
Language: | English |
Published: |
American Society for Biochemistry and Molecular Biology
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196100/ |
Similar Items
-
Stimulation of bone formation in cortical bone of the mice treated with a novel bone anabolic peptide with osteoclastogenesis inhibitory activity
by: Furuya, Yuriko, et al.
Published: (2012) -
Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity
by: Furuya, Yuriko, et al.
Published: (2013) -
From discovery of RANKL to clinical application of anti-human RANKL antibody
by: Yasuda, Hisataka, et al.
Published: (2012) -
Osteoclastic bone resorption directly activates osteoblast function
by: Udagawa, Nobuyuki
Published: (2012) -
Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone
Published: (1978)